eXoZymes Inc
EXOZ
6 hedge funds and large institutions have $880K invested in eXoZymes Inc in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
21% more capital invested
Capital invested by funds: $727K → $880K (+$153K)
0.19% less ownership
Funds ownership: 0.9% → 0.71% (-0.19%)
33% less funds holding
Funds holding: 9 → 6 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.8K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$26.8K |
| 3 |
BlackRock
New York
|
+$1.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$174K |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
-$19.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.28K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$142 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $383K | +$30.8K | +2,827 | +12% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $340K | +$26.8K | +2,464 | +12% |
|
|
3
BlackRock
New York
| $71.9K | +$1.57K | +144 | +3% |
|
|
4
UBS Group
Zurich,
Switzerland
| $66.7K | -$4.28K | -393 | -8% |
|
5
Morgan Stanley
New York
| $18K | – | – | – |
|
|
6
Bank of America
Charlotte,
North Carolina
| $332 | -$142 | -13 | -36% |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$174K | -18,144 | Closed |
|
|
8
Raymond James Financial
St Petersburg,
Florida
| – | -$19.8K | -2,000 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$3.4K | -344 | Closed |
|
EXOZ Hedge Fund Activity: Q3 2025 in Review
6 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in eXoZymes Inc (EXOZ) for Q3 2025, worth a combined $880K — up 21% from $727K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of EXOZ and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $30.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $174K sold.
- 6 institutional investors held eXoZymes Inc (EXOZ) as of Q3 2025, down from 9 in Q2 2025.
- Funds reported $880K of eXoZymes Inc stock for Q3 2025, up 21% quarter-over-quarter.
- 0 funds opened new eXoZymes Inc positions in Q3 2025 and 3 closed out, a net change of -3 holders.
- The largest eXoZymes Inc buyer in Q3 2025 was Vanguard Group, an estimated $30.8K added.
- The largest eXoZymes Inc seller in Q3 2025 was Citadel Advisors, an estimated $174K sold.
Based on aggregated 13F filings for Q3 2025.